Revenue

Alphatec's stellar financials are just the surface. We go inside the OR to see how its integrated procedural approach is winning surgeons and changing outcomes.

Nextdoor achieved its strongest financial quarter ever, swinging to a positive Adjusted EBITDA. We analyze the disciplined strategy that turned the corner.

While the broader pool industry treads water, Latham Group reports surging sales and raises its outlook. The secret? A strategic pivot to fiberglass pools and a targeted push into the Sun Belt.

Amid a biotech funding revival, Twist's upsized $300M deal signals a bold move to expand its synthetic biology platform, fueling a high-stakes investor debate.

Bed Bath & Beyond is dead. In its place rises Neighborhood Intelligence, a tech-driven titan aiming to conquer the entire homeownership lifecycle.

As RideNow Group preps its Q2 report, all eyes are on its unique pre-owned vehicle strategy. Can this digital-first approach rev up growth?

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.

A Tennessee museum, a major utility, and a top design firm are betting on superheroes to solve the energy sector's looming workforce crisis. Can a 'Powerverse' truly shape the future?

With a key hire from Activision Blizzard, Kartoon Studios is betting its future on monetizing classic IPs like Winnie the Pooh and the Stan Lee Universe. Is this the pivot that finally unlocks shareholder value?

With a sold-out festival and record digital reach, TryHard Holdings is disrupting Japan's live events. We unpack its powerful model of strategic partnerships and tech.

DDC Enterprise reports a 28% revenue surge, but the real story is how its food business funds an ambitious Bitcoin treasury and shareholder value strategy.

Pinnacle West's Q2 earnings fell despite soaring energy use from an early summer, revealing a critical challenge: balancing rising costs with investments in grid reliability.

TPG reports record first-half results, beating Q2 revenue and EPS estimates. The firm's diversified model and strong AUM growth signal robust health.

Healis Therapeutics gets FDA nod for Tyemvers, a botulinum toxin therapy for depression. Can a drug that paralyzes frown muscles disrupt mental healthcare?

With $15B in deals, Volta is treating AI compute like electricity, aiming to build a new utility for an industry constrained by capital, not just chips.

Amid a truck market slump, Core Molding Technologies reveals a strategic shift, leveraging new ventures in energy storage and a major expansion in Mexico.

The Department of War taps AI startup Kaizen to build a rapid procurement platform, signaling a major shift in how the U.S. counters asymmetric drone warfare.

Aemetis secures a $17M deal in India's booming biofuel market, but a look behind the numbers reveals a high-stakes play balancing massive growth against leverage.

Beneath stellar 38% revenue growth, Amex GBT's Q2 results reveal a strategy fueled by AI innovation, key client wins, and an impending private equity era.

Fortitude Mining is buying up Nebraska's power infrastructure. It's not just about mining Zcash; it's a calculated move to build a Wall Street-ready empire.